This compound is primarily utilized in the pharmaceutical industry as an active pharmaceutical ingredient (API) in the development of medications targeting central nervous system disorders. It functions as a serotonin-norepinephrine reuptake inhibitor (SNRI), making it effective in treating conditions such as depression, anxiety, and certain types of chronic pain. Its mechanism involves increasing the levels of serotonin and norepinephrine in the brain, which helps regulate mood and alleviate symptoms of these disorders. Additionally, it has been explored for its potential in managing neuropathic pain due to its ability to modulate neurotransmitter activity. The hydrochloride salt form enhances its stability and bioavailability, making it suitable for oral formulations. Research is ongoing to evaluate its efficacy in other therapeutic areas, including fibromyalgia and attention deficit hyperactivity disorder (ADHD).